Share on StockTwits

Alere (NYSE:ALR) was downgraded by equities research analysts at Goldman Sachs to a “sell” rating in a research note issued to investors on Wednesday.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Alere from $45.00 to $40.00 in a research note on Tuesday, August 5th. They now have a “buy” rating on the stock. Separately, analysts at Leerink Swann cut their price target on shares of Alere from $40.00 to $38.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of Alere from $50.00 to $45.00 in a research note on Tuesday, August 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. Alere currently has an average rating of “Hold” and an average target price of $42.60.

Shares of Alere (NYSE:ALR) opened at 36.24 on Wednesday. Alere has a 52-week low of $30.14 and a 52-week high of $40.80. The stock’s 50-day moving average is $36.6 and its 200-day moving average is $36.18. The company’s market cap is $3.011 billion.

Alere (NYSE:ALR) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.42 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.58 by $0.16. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $747.55 million. During the same quarter in the prior year, the company posted $0.64 earnings per share. The company’s quarterly revenue was down 3.4% on a year-over-year basis. Analysts expect that Alere will post $2.23 EPS for the current fiscal year.

Alere Inc is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease.

Receive News & Ratings for Alere Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.